LOCALIZATION OF THE E6-AP REGIONS THAT DIRECT HUMAN PAPILLOMAVIRUS E6 BINDING, ASSOCIATION WITH P53, AND UBIQUITINATION OF ASSOCIATED PROTEINS

被引:366
作者
HUIBREGTSE, JM [1 ]
SCHEFFNER, M [1 ]
HOWLEY, PM [1 ]
机构
[1] NCI, TUMOR VIRUS BIOL LAB, BETHESDA, MD 20892 USA
关键词
D O I
10.1128/MCB.13.8.4918
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
E6-AP is a 100-kDa cellular protein that mediates the interaction of the human papillomavirus type 16 and 18 E6 proteins with p53. The association of p53 with E6 and E6-AP promotes the specific ubiquitination and subsequent proteolytic degradation of p53 in vitro. We recently isolated a cDNA encoding E6-AP and have now mapped functional domains of E6-AP involved in binding E6, association with p53, and ubiquitination of p53. The E6 binding domain consists of an 18-amino-acid region within the central portion of the molecule. Deletion of these 18 amino acids from E6-AP results in loss of both E6 and p53 binding activities. The region that directs p53 binding spans the E6 binding domain and consists of approximately 500 amino acids. E6-AP sequences in addition to those required for formation of a stable ternary complex with E6 and p53 are necessary to stimulate the ubiquitination of p53. These sequences lie within the C-terminal 84 amino acids of E6-AP. The entire region required for E6-dependent ubiquitination of p53 is also required for the ubiquitination of an artificial E6 fusion protein.
引用
收藏
页码:4918 / 4927
页数:10
相关论文
共 46 条
[1]
TRANSCRIPTION FACTOR E2F IS REQUIRED FOR EFFICIENT EXPRESSION OF THE HAMSTER DIHYDROFOLATE-REDUCTASE GENE INVITRO AND INVIVO [J].
BLAKE, MC ;
AZIZKHAN, JC .
MOLECULAR AND CELLULAR BIOLOGY, 1989, 9 (11) :4994-5002
[2]
ADENOVIRUS-E1A, SIMIAN VIRUS-40 TUMOR-ANTIGEN, AND HUMAN PAPILLOMAVIRUS-E7 PROTEIN SHARE THE CAPACITY TO DISRUPT THE INTERACTION BETWEEN TRANSCRIPTION FACTOR-E2F AND THE RETINOBLASTOMA GENE-PRODUCT [J].
CHELLAPPAN, S ;
KRAUS, VB ;
KROGER, B ;
MUNGER, K ;
HOWLEY, PM ;
PHELPS, WC ;
NEVINS, JR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (10) :4549-4553
[3]
DEGRADATION OF P53 CAN BE TARGETED BY HPV E6 SEQUENCES DISTINCT FROM THOSE REQUIRED FOR P53 BINDING AND TRANSACTIVATION [J].
CROOK, T ;
TIDY, JA ;
VOUSDEN, KH .
CELL, 1991, 67 (03) :547-556
[4]
CROOK T, 1991, ONCOGENE, V6, P873
[5]
DURST M, 1987, ONCOGENE, V1, P251
[6]
THE HUMAN PAPILLOMA VIRUS-16 E7-ONCOPROTEIN IS ABLE TO BIND TO THE RETINOBLASTOMA GENE-PRODUCT [J].
DYSON, N ;
HOWLEY, PM ;
MUNGER, K ;
HARLOW, E .
SCIENCE, 1989, 243 (4893) :934-937
[7]
WILD-TYPE P53 CAN INHIBIT ONCOGENE-MEDIATED FOCUS FORMATION [J].
ELIYAHU, D ;
MICHALOVITZ, D ;
ELIYAHU, S ;
PINHASIKIMHI, O ;
OREN, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (22) :8763-8767
[8]
WILD-TYPE P53 ACTIVATES TRANSCRIPTION INVITRO [J].
FARMER, G ;
BARGONETTI, J ;
ZHU, H ;
FRIEDMAN, P ;
PRYWES, R ;
PRIVES, C .
NATURE, 1992, 358 (6381) :83-86
[9]
THE P53 PROTO-ONCOGENE CAN ACT AS A SUPPRESSOR OF TRANSFORMATION [J].
FINLAY, CA ;
HINDS, PW ;
LEVINE, AJ .
CELL, 1989, 57 (07) :1083-1093
[10]
UBIQUITINATION [J].
FINLEY, D ;
CHAU, V .
ANNUAL REVIEW OF CELL BIOLOGY, 1991, 7 :25-69